# Aveir VR Real-World Evidence Post-Approval Study

> **NCT05270499** · — · RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 2100 (estimated)

## Conditions studied

- Cardiac Pacemaker
- Arrythmia
- Bradycardia

## Interventions

- **DEVICE:** Aveir VR Leadless Pacemaker System

## Key facts

- **NCT ID:** NCT05270499
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2034-02-28
- **Final completion:** 2034-02-28
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270499, "Aveir VR Real-World Evidence Post-Approval Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05270499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*